Developing and manufacturing vaccines for infectious diseases
Task V26: The Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of services spanning product development planning and
This study is all about creating and improving new vaccines to help protect people from infectious diseases, making sure they meet safety standards, so that patients can benefit from better protection against illnesses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-10168819 on NIH RePORTER |
What this research studies
This research focuses on providing essential services for the development and manufacturing of vaccines and biologics aimed at combating infectious diseases. It includes planning and feasibility assessments, product optimization, and compliant manufacturing for early-phase clinical studies. The project also involves conducting technical audits and providing regulatory support to ensure that new vaccines meet FDA standards. Patients may benefit from the introduction of new vaccines that protect against emerging infectious threats.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for infectious diseases or those involved in clinical trials for new vaccines.
Not a fit: Patients with established immunity to the targeted infectious diseases or those not at risk for such diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect patients from infectious diseases and bioterrorism threats.
How similar studies have performed: Other research has shown success in developing vaccines using similar methodologies, indicating a promising approach to vaccine development.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Fouts, Tim — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Tim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.